Discover the full directors' dealings record of 원바이오젠, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 원바이오젠 has published 15 insider filings. The latest transaction was reported on 21 November 2024 (Sale). Among the most active insiders: 교보증권. The full history is openly available.
15
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
11 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.